CSPC Pharmaceutical Group Limited (1093.HK) HKSE
7.16
-0.41(-5.42%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 96.3B |
| Enterprise Value | 90.85B |
| P/E Ratio | 19.74 |
| PEG Ratio | -2.43 |
| Price/Sales Ratio | 2.92 |
| Price/Book Ratio | 2.27 |
| Enterprise/Revenue | 2.7 |
| Enterprise/EBITDA | 11.79 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.15 |
Management Effectiveness
| Return On Assets | 0.08 |
| Return On Equity | 0.11 |
Income Statement
| Revenue | 25.33B |
| Revenue/Share | 2.22 |
| Gross Profit | 16.62B |
| EBITDA | 5.24B |
| Net Income | 3.78B |
| Diluted EPS | 0.33 |
Balance Sheet
| Total Cash | 8.87B |
| Total Cash/Share | 0.77 |
| Total Debt | 641.38M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 2.19 |
| Book Value Per Share | 3 |
Price History
| 52-Week Change | -1.82 |
| 52-Week High | 11.63 |
| 52-Week Low | 6.64 |
| Moving Average 50 Days | 8.52 |
| Moving Average 200 Days | 8.98 |
Statistics
| Average Volume | 93.88M |
| Shares Outstanding | 11.41B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.21 |
| Trailing Annual Dividend Yield | 3.17 |
| Payout Ratio | 0.64 |
| Last Split Factor | 8:5 |
| Last Split Date | October 15, 2020 |
